Diane-35

Diane 35 is a combination antiandrogen/estrogen for use in the treatment of androgen-dependant dermatological conditions in females. Diane 35, as with all estrogen/progesteron combinations, is contraindicated in women with thrombophlebitis, thromboembolic disorders, or a history of these conditions.

Diane 35 users appear to have an elevated risk of venous thromboembolic events compared to users of combination oral contraceptives  in some published studies.  Estrogen and /or progesteron should not be taken during treatment with Diane 35. Diane 35 should not be prescribed for the purpose of contraception alone.

During treatment with Diane 35, other oral contraceptives should not be used.  Diane 35 should be discontinued 3 to 4 cycles after signs have completely resolved.

See Birth Control Statistics for information on birth control pills.